Miles Chapman

776 total citations
20 papers, 490 citations indexed

About

Miles Chapman is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Miles Chapman has authored 20 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 9 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Miles Chapman's work include Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Neurosurgical Procedures and Complications (4 papers). Miles Chapman is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Neurosurgical Procedures and Complications (4 papers). Miles Chapman collaborates with scholars based in United Kingdom, Sweden and Slovakia. Miles Chapman's co-authors include Axel Petzold, Ahmed K. Toma, Laurence Watkins, Henrik Zetterberg, Geoff Keir, Neil Kitchen, Michael P. Lunn, Andrew Tarnaris, Nick C. Fox and Jonathan M. Schott and has published in prestigious journals such as Journal of neurosurgery, Experimental Neurology and Journal of Immunological Methods.

In The Last Decade

Miles Chapman

17 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miles Chapman United Kingdom	12	202	163	161	132	85	20	490
Eino Solje Finland	14	273 1.4×	215 1.3×	72 0.4×	165 1.3×	111 1.3×	51	568
Simona Petrucci Italy	16	453 2.2×	135 0.8×	195 1.2×	99 0.8×	132 1.6×	43	755
Marta Scarioni Italy	14	197 1.0×	149 0.9×	43 0.3×	131 1.0×	60 0.7×	23	488
Evangelos Pavlou Greece	15	255 1.3×	267 1.6×	115 0.7×	203 1.5×	171 2.0×	48	747
Karsten Henkel Germany	12	95 0.5×	97 0.6×	90 0.6×	183 1.4×	218 2.6×	18	566
Tiziana Carandini Italy	18	124 0.6×	124 0.8×	83 0.5×	130 1.0×	121 1.4×	43	658
Grace Liang United States	16	593 2.9×	58 0.4×	274 1.7×	219 1.7×	120 1.4×	47	936
K. Meng Tan Australia	10	365 1.8×	58 0.4×	115 0.7×	169 1.3×	129 1.5×	25	637
Stefano Gipponi Italy	15	322 1.6×	100 0.6×	37 0.2×	249 1.9×	56 0.7×	33	644
C. Sfagos Greece	13	148 0.7×	76 0.5×	91 0.6×	76 0.6×	72 0.8×	24	527

Countries citing papers authored by Miles Chapman

Since Specialization

Citations

This map shows the geographic impact of Miles Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles Chapman more than expected).

Fields of papers citing papers by Miles Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles Chapman. The network helps show where Miles Chapman may publish in the future.

Co-authorship network of co-authors of Miles Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Miles Chapman. A scholar is included among the top collaborators of Miles Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles Chapman. Miles Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheema, Sanjay, et al.. (2025). Serum cytokines in primary new daily persistent headache and chronic migraine: a case control study. Frontiers in Neurology. 16. 1547124–1547124.

Brown, Rachel, Gilbert Thomas‐Black, Héctor García‐Moreno, et al.. (2025). GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice. Journal of Neurology. 272(3). 222–222.

Chapman, Miles, et al.. (2025). Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper. Cureus. 17(11). e96247–e96247.

Keshavan, Ashvini, Miles Chapman, Melanie Hart, et al.. (2022). CSF biomarkers for dementia. Practical Neurology. 22(4). 285–294. 8 indexed citations

Keshavan, Ashvini, Henrietta Wellington, Zhongbo Chen, et al.. (2021). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12131–e12131. 31 indexed citations

Keshavan, Ashvini, Henrietta Wellington, Zhongbo Chen, et al.. (2020). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12097–e12097. 14 indexed citations

Paterson, Ross W., Catherine F. Slattery, Teresa Poole, et al.. (2018). Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer s Research & Therapy. 10(1). 32–32. 105 indexed citations

Craven, Claudia, Henrik Zetterberg, Michael P. Lunn, et al.. (2017). The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus. Acta Neurochirurgica. 159(12). 2293–2300. 19 indexed citations

Paterson, Ross W., Catherine F. Slattery, Nadia Magdalinou, et al.. (2016). O1‐11‐05: CSF In the Differential Diagnosis of Alzheimer's Disease: Clinical Utility of an Extended Panel Of Biomarkers in a Specialist Cognitive Clinic. Alzheimer s & Dementia. 12(7S_Part_4). 1 indexed citations

10.

Paterson, Ross W., Jamie Toombs, Miles Chapman, et al.. (2015). Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 1(3). 380–384. 6 indexed citations

11.

Kawagashira, Yuichi, Haruki Koike, Ken Ohyama, et al.. (2014). Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. Journal of the Neurological Sciences. 348(1-2). 67–73. 22 indexed citations

12.

Toombs, Jamie, Ross W. Paterson, Michael P. Lunn, et al.. (2013). Identification of an important potential confound in CSF AD studies: aliquot volume. Clinical Chemistry and Laboratory Medicine (CCLM). 51(12). 2311–2317. 34 indexed citations

13.

Tarnaris, Andrew, Ahmed K. Toma, Miles Chapman, et al.. (2011). Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus. Alzheimer s & Dementia. 7(5). 501–508. 41 indexed citations

14.

Tarnaris, Andrew, Ahmed K. Toma, Miles Chapman, et al.. (2011). Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. Journal of neurosurgery. 115(1). 145–150. 33 indexed citations

15.

Tarnaris, Andrew, Ahmed K. Toma, Miles Chapman, et al.. (2010). Rostrocaudal Dynamics of CSF Biomarkers. Neurochemical Research. 36(3). 528–532. 35 indexed citations

16.

Petzold, Axel, Djordje Gverić, Mike Groves, et al.. (2008). Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology. Experimental Neurology. 213(2). 326–335. 58 indexed citations

17.

Giovannoni, Gavin, Miles Chapman, & Edward J. Thompson. (2006). The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders. Journal of Neuroimmunology. 180(1-2). 29–32. 4 indexed citations

18.

Chapman, Miles, Geoffrey Keir, Axel Petzold, & Edward J. Thompson. (2006). Measurement of high affinity antibodies on antigen-immunoblots. Journal of Immunological Methods. 310(1-2). 62–66. 15 indexed citations

19.

Chapman, Miles, et al.. (2004). No Evidence for Production of Intrathecal Immunoglobulin G against <i>Acinetobacter</i> or <i>Pseudomonas</i> in Multiple Sclerosis. European Neurology. 53(1). 27–31. 3 indexed citations

20.

Church, Andrew J., Russell C. Dale, Francisco Cardoso, et al.. (2003). CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?. Journal of Neuroimmunology. 136(1-2). 149–153. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact